Join the Oncology Voice Network. Join for Free
How I landed my first MSL role... what works, what doesn't, and what you need to know
Medical Science Liaison MSL role tips job search strategies MSL interview preparation networking for MSLs

How I landed my first MSL role... what works, what doesn't, and what you need to know


Share This Article


Summary

In this episode, Julie Chen shares her journey and insights into the MSL role, emphasizing the importance of confidence, preparation, and overcoming challenges in the job search. She discusses strategies for tailoring CVs, leveraging mentorship, and building essential skills for aspiring MSLs. Julie highlights the significance of networking and managing job search frustrations while offering advice on interview preparation and the necessity of attention to detail. The episode concludes with Julie's reflections and gratitude, followed by a call to action for listeners to engage with the content.

My guest today is Julie Chen, Medical Science Liaison at Janssen Cardiology. We discuss how she landed her first MSL role and what advice she has for aspiring MSLs looking to break into the role.

In this episode we discuss:

  • Julie’s background
  • Why she wanted to be an MSL
  • The story of her job search
  • Steps she took to initiate her search and what worked well
  • The challenges she faced
  • Her mentors/coaches
  • Absolute MUSTs for anyone seeking to land an MSL role
  • Overcoming frustrations
  • The advice she can offer and what else aspiring MSLs should keep in mind

Click for Source
Medical Science Liaison, MSL role tips, job search strategies, MSL interview preparation, networking for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions
OVN Avatar Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Explore OVN